Karius is a venture-backed life science startup dedicated to revolutionizing the detection and understanding of pathogens and microbes within the human body. By leveraging advanced genomic sequencing and machine learning technologies, Karius provides clinicians with a comprehensive testing platform capable of identifying over a thousand pathogens directly from blood samples. This innovative approach not only aids in the rapid diagnosis of infectious diseases but also supports industry partners in biomarker discovery and clinical trials, ultimately aiming to reduce patient suffering on a global scale. The Karius team, composed of scientists, statisticians, engineers, and physicians, is united by a mission to improve patient care through groundbreaking advancements in microbial analysis.